Navigation Links


ERG at biology technology

High-Level Expression of Peanut Allergens Affected by Rare Codon Usage

Biochemical & Molecular Allergology, Research Center Borstel, Germany By using Stratagenes BL21-CodonPlus(DE3)-RIL cells * withextra copies of E. coli, argU, ileY, and leuW tRNA genes,it is possible to attain high-level expression...

Restriction Endonucleases Undergo Rigorous QC Testing to Ensure Optimal Performance

Stratagene Restriction endonucleases are used in many molecular biology protocols,making the functional purity of critical importance. Each restriction enzymepreparation must be free of contaminants that can potentiall...

Ergonomics and Liquid Handling How can BrinkmannTM Help ?

How can Brinkmann As a laboratory technician, pipetting is a routine laboratory technique that is performed everyday, for a good portion of the day. Pipetting work demands concentration, accuracy and preci...

Quantitation of Cabergoline at Extremely Low Plasma Concentrations with a Triple Quadrupole Mass Spectrometer

Nicola Hughes, Jean-Jacques Dunyach, 1Biovail Contract Research,Toronto,Ontario,Canada; 2Thermo Finnigan,San Jose,CA,USA; 3Therm...

Quantification of the Purinergic Receptor P2X3 using ICAT and Orthogonal 2D LC-MS/MS with an Ion Trap Mass Spectrometer

David Barnidge , Gargi Choudhary Neuromics, Inc., Minneapolis, MN Thermo Finnigan, San Jose, CA The data presented here was acquired using the Proteome...

Fergus joins Baird Venture Partners, Caden Bio

Fergus, a graduate who will be b...

Merge Healthcare hires new VP of finance

Merge announced the hiring of Greg Wilson, currently the chief financial officer with <a href="http://w...

Wisconsin will have plenty of competition in building the energy future

A. It's time to win the race to become the energy capital of the world. B. To lead, we must innovate and provide new sources of energy to power our lives and propel our state's economy forward. C. Let's show the nation how to move even more boldly toward energy independence.<b...

Schwartz leaves Merge board; will launch healthcare technology investment fund

Schwartz will continue providing business development assistance to the company beyond his previously...

Drug innovation beats marketing, patents and mergers

While Genentech had revenues of $4.6 b...

Merge eFilm earnings jump precedes planned merger

That's a 22 percent increase over first q...

Merge eFilm announces rapid growth in first quarter

MILWAUKEE -- Merge Technologies Inc. announced Wednesday that its net sales are up 41 percent in first-quarter 2004, compared to first-quarter 2003. The Milwaukee-based company, which does business as RIS Logic's pro...

Technology and business merge at UW Burrill Competition

MADISON The seventh annual The main goal is to give students ac...

Merge eFilm Builds Distribution Channel

MILWAUKEE, WI - - has signed agreements with four European companies to resell or distribute Merge eFilm's FUSION RIS/PACS and eFilm Workstation solutions. These full-service healthcare solution firms will increase the availability of Merge eFilm's products and services throughout European healthcare organisat...

Rapid hit confirmation and early hERG liability testing using the IonWorks HT system

By James Costantin, Ph.D., Yen-Wen Chen, Ph.D., Jinfang Liao, Ph.D., Jeff Quast, Andrew Wittel, Shawn Handran, Ph.D. and Naibo Yang, Ph.D. Molecular Devices Corporation...

Detection, identification, and quantitation of an olive allergen using Ettan MDLC, MS/MS, and DeCyder MS

multidimensional liquid chromatography (MDLC) • reversed-phase chromatography (RPC) • LC-MS/MS • DeCyder MS • differential analysis Ettan™ MDLC was used in conjunction with tandem mass spectrometry (MS/MS) to separate and identify allergenic proteins extracted from the pollen of the olive tre...

Screening for potential beta 2-adrenergic receptor antagonists using CypHer5E and IN Cell Analyzer 1000

5, a pH sensitive dye, has shown utility in β2-adrenergic receptor agonist screening (1). CypHer5 has been used to obtain dose-response and rank-order potency data for both agonist and antagonist treatment of β2-adrenergic receptor expressing cells (2). For live-cell receptor internalization studies,...

Screening for β2-adrenergic receptor agonists using the pH-sensitive dye,CypHer5, and the IN Cell Analyzer 3000

High-throughput screening for potential targets is a major requirement in drug development and a key application is in the area of receptor activation, particularly G-protein coupled receptors (GPCRs) (1). <P >It is estimated that there are still 100–200 orphan GPCRs of potential therapeutic value requiring identification of...

Development of an adrenergic α2a receptor binding assay using the LEADseeker Multimodality Imaging System

The α +...

Monitoring fluorescence resonance energy transfer (FRET) between GFP fusions in lysates of the yeast Saccharomyces cerevisiae using the Varian Cary Eclipse

fusions in lysates of the yeast Saccharomyces cerevisiae using the Varian Cary Eclipse Department of Biochemistry and Molecular Biol...

Chemical-petroleum executive joins Virent Energy board

Virent, which recently entered into an agreement with , a subsidiary of Shell Oil Co., is developing technologies that allow the renewable...

Federal bioenergy lab will give Wisconsin a chance to shine

The , was pioneering scientific...

Merge launches diagnostic mammography workstation in Europe

Merge, a medical imaging software and services provider, said the workstation, known commercially as Merge Mammo version...

UW-Madison to receive $125M for bioenergy research center

The <a href="http://www.news.wisc.edu/13...

Madison energy firm lands $275K foreign grant

The Madison-based energy business announced it will receive a technology climate action grant, and the source of the grant comes from down under - the New Sou...

Madison to receive funding as part of $60M solar energy program

Solar America Cities, which is part of a $60 million DOE announced by DOE Secretary Samuel...

Technology and mergers: Getting the strategic applications

The current dilemma...

Legislature should look to Wisconsin's natural energy advantages

That question was raised by state...

Barriers will not stop convergence of medical technologies

During residency, which is not the free-for-all carnival that Gray's Anatomy would have us believe, one of the most important judgment calls that is learned is whether the patien...

Merge Technologies' net loss doubles to $10.1M

While the first quarter loss was well below the $27.0 million, or $0.80 per share net loss reported in the fourth quarter of...

Merge unveils next-generation imaging-informatics product

Merge, a medical imaging software and services company, will market the product, which is called Fusion RIS/PACS, to im...

Personalized medicine and technology convergence

It's been one year since the debut of MedTech Futures and it has been a pleasure and a privilege to have the opportunity to share ideas with through this forum. As this column enters its second year, I wanted to take an opportunity to briefly summarize some of the perspectives over the past year and also discuss a topic of great timeliness and importance - namely pe...

Doyle announces new energy, global warming policies

Doyle officially created the Office of Energy Independence, appointed a global warming task force, and said Wisconsin will be part of a renewable energy credit trading sy...

Merge unveils updated medical imaging software

Merge, which has released several product upgrades this year as it attempts to recover from past financial reporting improprieties, said...

Wisconsin can offer what a federal energy research lab needs

State businesses, architects, and builders are national leaders in planning and constructing green buildings...

Kettner to leave WARF, join Virent Energy Systems

Kettner, who has emphasized biotech patent prosecution and intellectual property licensin...

Merge Healthcare suffers $258M loss in `06

The loss, which included a goodwill impairment...

Merge Healthcare unveils diagnostic mammography tool

According to Merge, the vendor-neutral product, marketed as Merge Mammo(TM) version 7.0, will make possible simultaneous display and reading of images on d...

Bio-energy and cleantech grab attention of investors

- In 2000, so-called cleantech investments made up only one percent of the venture capital market in the United States. By late 2006, that slice of the venture capital pie had grown to 14 percent. The message is clear: The markets are warming to technologies that produce alternative fuels, keep the air and water clean, and help conserve energy.<...

Johnson Controls adds renewable energy unit

The company's new renewable technologies unit will focus on geothermal, solar, biomass, wind, and other alternative sources of e...
Other TagsCHPVHakimMachMachMachMachMachHeadrestTTSTTSTTS
(Date:11/23/2009)... Washington, D.C. The community-associated strain...acteria resistant to most common antibioticsposes ...and is making its way into hospitals, according to...ious Diseases . , The new threat is easily pick...c places and has increased the overall burden of M...
(Date:11/23/2009)... Farmington, CT Current research suggests that a ...sease. The related report by Nichols et al, "Uniq...a New Class of TLR2 Ligands Capable of Enhancing A...f The American Journal of Pathology . , Multipl...m attacks the brain and spinal cord, affects nearl...
(Date:11/23/2009)..., BIRMINGHAM, Ala. A new study by University o...at body-mass index (BMI) and co-existing medical c...sed survival observed among African-Americans comp... study is published online Nov. 23 in Cancer , a ...nding indicates that although BMI and co-morbidity...
Breaking Biology News(10 mins):New study finds MRSA on the rise in hospital outpatients 2Factors from common human bacteria may trigger multiple sclerosis 2Racial disparity in colon cancer survival not easily explained, UAB researchers say 2Large Study of Anemia Treatment in Chronic Kidney Disease Patients Not on Dialysis Published in the New England Journal of Medicine Failed to Meet Pri 60445 1Large Study of Anemia Treatment in Chronic Kidney Disease Patients Not on Dialysis Published in the New England Journal of Medicine Failed to Meet Pri 60445 2Large Study of Anemia Treatment in Chronic Kidney Disease Patients Not on Dialysis Published in the New England Journal of Medicine Failed to Meet Pri 60445 3Large Study of Anemia Treatment in Chronic Kidney Disease Patients Not on Dialysis Published in the New England Journal of Medicine Failed to Meet Pri 60445 4Large Study of Anemia Treatment in Chronic Kidney Disease Patients Not on Dialysis Published in the New England Journal of Medicine Failed to Meet Pri 60445 5Large Study of Anemia Treatment in Chronic Kidney Disease Patients Not on Dialysis Published in the New England Journal of Medicine Failed to Meet Pri 60445 6Large Study of Anemia Treatment in Chronic Kidney Disease Patients Not on Dialysis Published in the New England Journal of Medicine Failed to Meet Pri 60445 7Large Study of Anemia Treatment in Chronic Kidney Disease Patients Not on Dialysis Published in the New England Journal of Medicine Failed to Meet Pri 60445 8Large Study of Anemia Treatment in Chronic Kidney Disease Patients Not on Dialysis Published in the New England Journal of Medicine Failed to Meet Pri 60445 9NAMI Applauds Initial Review of The Affordable Health Care of America Act and Health Care Reform 60444 1NAMI Applauds Initial Review of The Affordable Health Care of America Act and Health Care Reform 60444 2NAMI Applauds Initial Review of The Affordable Health Care of America Act and Health Care Reform 60444 3Company C Donates 2440 000 To Fight Breast Cancer 60442 1Company C Donates 2440 000 To Fight Breast Cancer 60442 2
(Date:11/25/2009)...ILVERSPRING,Md.,Nov.25/PRNewswire-USNewswire/--Ana...rforDrugEvaluationandResearch,titled"ADifficultBal...ntheNov.26,2009issueofTheNewEnglandJournalofMedici...nh/20090824/FDALOGO ) ,, Inthearticle,Woodcockd...ainmedicationforthosewhoneeditandmanagingtherisksp...
(Date:11/25/2009)...hers have found evidence of a statistically signif...ng patients whose estrogen receptor (ER)-positive ...pha; at serine-118 (ER-alpha S118-P), according to...5 in the Journal of the National Cancer Institute...resistant to tamoxifen. Preclinical studies have s...
(Date:11/25/2009)... Evaluation and treatment clinics ... Woodstock (Vocus) November 25, 2009 -- Centegra...accines and H1N1 vaccine shots at four Centegra Pr... shipment of vaccine has arrived. The clinics are ...nd McHenry and will be open as follows: , &nbs...
(Date:11/25/2009)...RLINGTON,Va.,Nov.25/PRNewswire-USNewswire/--TheAme...ealthCareFraudActof2009,"S.2128,whichisdesignedtos...ventfraudinMedicare.ThebillwasintroducedbySen.Geor...eralprovisionstheAmericanAssociationforHomecareout...ociationproposedtoCongressinFebruary.Thoseprovisio...
(Date:11/25/2009)...disks placed under the skin kill tumor cells, stud...y News) -- A cancer vaccine delivered in a fingern...e, a new study reports. , The method uses polym...aded with tumor-specific antigens and implanted un...ack tumors. The Harvard University scientists who ...
Breaking Medicine News(10 mins):Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4Health News:American Association for Homecare Endorses New U.S. Senate Bill, the 'Prevent Health Care Fraud Act of 2009' 2
Other Contentshomozygoushomozygoushomozygoushomozygoushorizontalhorizontalhorizontalhorizontalhorizontalhorizontalhorizontalhormoneshormoneshormoneshormoneshormoneshormoneshormoneshormoneshosthosthosthosthosthosthosthosthostinitiativeinitiativeinitiativeinitiative